Archive

Hits: 1370
Bìol. Tvarin, 2018, volume 20, issue 3, pp. 30–36

THE CONDITION OF THE PROOXIDANT-ANTIOXIDANT SYSTEM IN SKELETAL MUSCLES OF EXPERIMENTALLY DIABETIC RATS UNDER VANADIUM CITRATE EFFECT

R. Iskra, H. Klymets, O. Sushko, L. Ponkalo, O. Svarchevska

This email address is being protected from spambots. You need JavaScript enabled to view it.

Institute of Animal Biology NAAS,
38 V. Stus str., Lviv 79034, Ukraine

The effect of vanadium citrate on the content of lipid peroxide oxidation products, reduced glutathione, the activity of the antioxidant system enzymes and glucose-6-phosphate dehydrogenase in the thigh skeletal muscles of alloxan-induced diabetic rats was studied. Animals were divided into five groups: I group — control, II, III, IV and V — experimental. The rats of I and II groups were given pure water to drink, whereas a solution of vanadium citrate at concentrations of 0.125, 0.5 and 2.0 μg V/ml of water was added to drinking water of III, IV and V groups within a month. The animals of all experimental (II–V) groups were induced diabetes by intraperitoneal injection of alloxan (150 mg/kg body weight).

In muscles of the II group experimentally diabetic animals, the increase in the content of hydroperoxides and TBA-active products and the decrease in the activity of antioxidant protection enzymes (superoxide dismutase, catalase and glutathione reductase), glucose-6-phosphate dehydrogenase and the content of reduced glutathione were observed, while the activity of glutathione peroxidase increased as compared to control animals. Under watering vanadium citrate at different concentrations, there was a decrease in the content of hydroperoxides (in III, IV and V groups) and TBA-active products (in group III), but the increase in the activity of superoxide dismutase and catalase (in group V), glutathione reductase (in III, IV and V groups), glucose-6-phosphate dehydrogenase (in IV and V groups), and the content of reduced glutathione (in group V), while glutathione peroxidase activity decreased (in III, IV and V groups), as compared to the muscle indexes in experimentally diabetic animals of the II group. Vanadium citrate at the concentrations under investigation has a dose-dependent stabilizing effect on the condition of the prooxidant-antioxidant system in skeletal muscles of experimentally diabetic rats.

Keywords: VANADIUM CITRATE, ANTIOXIDANT SYSTEM, DIABETES, SKELETAL MUSCLES, RATS

  1. Altomare E., Vendemiale G., Chicco D., Procacci V., Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabetes & Metabolism, 1992, vol. 18, no. 4, pp. 264–271.
  2. Aragno M., Mastrocola R., Catalano M. G., Brignardello E., Danni O., Boccuzzi G. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes, 2004, vol. 53, no. 4, pp. 1082–1088. https://doi.org/10.2337/diabetes.53.4.1082
  3. Askar M., Vijay S., McNeill J. H. Vanadium increases GLUT4 in diabetic rat skeletal muscle. Molecular and Cellular Biochemistry, 2002, vol. 233, issue 1–2, pp. 139–143. https://doi.org/10.1023/A:1015558328757
  4. Etuk E. U. Animals models for studying diabetes mellitus. Agric. Biol. J. N. Am., 2010, vol. 1, no. 2, pp. 130–134.
  5. Ganea E., Harding J. J. Molecular chaperones protect against glycation-induced inactivation of glucose-6-phosphate dehydrogenase. Eur. J. Biochem., 1995, vol. 231, issue 1, pp. 181–185. https://doi.org/10.1111/j.1432-1033.1995.tb20684.x
  6. Giacco F., Brownlee M., Schmidt A. M. Oxidative stress and diabetic complications. Circ. Res., 2010, vol. 107, no. 9, pp. 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
  7. He J., Watkins S., Kelley D. E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes, 2001, vol. 50, no. 4, pp. 817–821. https://doi.org/10.2337/diabetes.50.4.817
  8. Jacob S., Machann J., Rett K., Brechtel K., Volk A., Renn W., Maerker E., Matthaei S., Schick F., Claussen C. D., Häring H. U. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetc offspring of type 2 diabetic subjects. Diabetes, 1999, vol. 48, no. 5, pp. 1113–1119. https://doi.org/10.2337/diabetes.48.5.1113
  9. Jiang P., Du W., Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell, 2014, vol. 5, issue 8, pp. 592–602. https://doi.org/10.1007/s13238-014-0082-8
  10. Khavrona O. P. Disturbances of function of the glutathione antioxidant system in gastric mucosa, liver and erythrocytes of rats with experimental gastric lesions. Experimental and clinical physiology and biochemistry, 2015, no.1, pp. 26–31. (in Ukrainian)
  11. Kosinov M. V., Kaplunenko V. G. Ukrainian patent for utility model number 38391. IPC (2006): C07C 51/41, C07F 5/00, C07F 15/00, C07C 53/126 (2008.01), C07C 53/10 (2008.01), A23L 1/00, B82B 3/00. Method metal carboxylates “Nanotechnology receiving metal carboxylates”. Publish. 12.01.2009, Bull. no. 1. (in Ukrainian)
  12. Kreider R. B. Dietary supplements and the promotion of muscle growth with resistance exercise, Sports Med., 1999, vol. 27, issue 2, pp. 97–110. https://doi.org/10.2165/00007256-199927020-00003
  13. Krentz A. J. Insulin resistance. BMJ, 1996, vol. 313, no. 7069, pp. 1385–1389. https://doi.org/10.1136/bmj.313.7069.1385
  14. Lee-Young R. S., Hoffman N. J., Murphy K. T., Henstridge D. C., Samocha-Bonet D., Siebel A. L., Iliades P., Zivanovic B., Hong Y. H., Colgan T. D., Kraakman M. J., Bruce C. R., Gregorevic P., McConell G. K., Lynch G. S., Drummond G. R., Kingwell B. A., Greenfield J. R., Febbraio M. A. Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle. Mol. Metab., 2016, vol. 5, issue 11, pp. 1083–1091. https://doi.org/10.1016/j.molmet.2016.09.002
  15. Maritim A. C., Sanders R. A., Watkins J. B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol., 2003, vol. 17, issue 1, pp. 24–38. https://doi.org/10.1002/jbt.10058
  16. Ramachandran B., Kandaswamy M., Narayanan V., Subramanian S. Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats. Diabetes Obes. Metab., 2003, vol. 5, issue 6, pp. 455–461. https://doi.org/10.1046/j.1463-1326.2003.00302.x
  17. Rehder D. Biological and medicinal aspects of vanadium. Inorganic Chemistry Communications, 2003, vol. 6, issue 5, pp. 604–617. https://doi.org/10.1016/S1387-7003(03)00050-9
  18. Shilpashree Y. D., Tejaswi H. L. Lipid peroxidation and superoxide dismutase activities in patients with type 2 diabetes complicated with peripheral neuropathy. Int. J. Res. Med. Sci., 2016, vol.4, no. 2, pp. 457–460. https://doi.org/10.18203/2320-6012.ijrms20160295
  19. Smith D. M., Pickering R. M., Lewith G. T. A systematic review of vanadium oral supplements for glycaemic control in type II diabetes mellitus. QJM, 2008, vol. 101, issue 5, pp. 351–358. https://doi.org/10.1093/qjmed/hcn003
  20. Srivastava P., Saxena A. K., Kale R. K., Baquer N. Z. Insulin like effects of lithium and vanadate on the altered antioxidant status of diabetic rats. Res. Comon. Chem. Pathol. Pharmacol., 1993, vol. 80, no. 3, pp. 283–293.
  21. Stefanov A. V., Derimedved L. V., Churilova I. V. Clinicoexperimental justification of using of superoxidedismutase in medicine. NFaU “Zolotye. Stranitsy”, 2004, 288 p. (in Russian)
  22. Stump C. S., Henriksen E. J., Wei Y., Sowers J. R. The metabolic syndrome: role of skeletal muscle metabolism. Ann. Med., 2006, vol. 38, issue 6, pp. 389–402. https://doi.org/10.1080/07853890600888413
  23. Subramanian S. P., Pillai S. I., Kandaswamy M. Evaluation of antioxidant efficacy of vanadium-3-hydroxyflavone complex in streptozotocin-diabetic rats. Chemico-Biological Interactions, 2013, vol. 204, issue 2, pp. 67–74. https://doi.org/10.1016/j.cbi.2013.04.012
  24. Tsiani E., Bogdanovic E., Sorisky A., Nagy L., Fantus I. G. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and Glut translocation in muscle cells by a mechanism independent of phsophatidylinositol-3-kinase and protein kinase C. Diabetes, 1998, vol. 47, no. 11, pp. 1676–1686. https://doi.org/10.2337/diabetes.47.11.1676
  25. Tsutsui H., Kinugawa S., Matsushima S., Yokota T. Oxidative stress in cardiac and skeletal muscle dysfunction associated with diabetes mellitus. J. Clin. Biochem. Nutr., 2011, vol. 48, issue 1, pp. 68–71. https://doi.org/10.3164/jcbn.11-012FR
  26. Vlizlo V. V. (ed.), Fedoruk R. S., Ratych I. B. Laboratory methods of research in biology, veterinary medicine. A guide. Lviv, Spolom, 2012, 764 p. (in Ukrainian)
  27. Xu Y., Osborne B. W., Stanton R. C. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. AJP Renal. Physiol., 2005, vol. 289, issue 5, pp. F1040–F1047. https://doi.org/10.1152/ajprenal.00076.2005

Download full text in PDF

gslogoICLOGO

cr

nbuv

WorldCat Logo

oa

Search